Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer

Download real time

936.45 -6.05 (-0.64%)

546.1K NSE+BSE Volume

NSE 01 Dec, 2025 3:59 PM (IST)

94,228.8

Market Cap

High in industry

-

Beta 1Year

Low volatility

US FDA Approval

Zydus Life gets US FDA nod for Empagliflozin & Linagliptin tablets with a market size of $215.8 mn See details

Zydus Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ZYDUSLIFE, BSE:532321 Zydus Lifesciences Ltd.

Is Cadila Healthcare Ltd. worth buying?

864 Votes:

Buy 81.94%

Sell 9.95%

Hold 8.1%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Buy SEE REPORTS >